Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseGlobal Initiative for Chronic Obstructive Lung Disease2014
   Google Scholar
• ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet200737076577317765526
   PubMed Web of Science ®Google Scholar
• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med20063e44217132052
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSRodriguez-RoisinRThe 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (gold) – why and what?Clin Respir J2012620821422906068
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
   PubMed Web of Science ®Google Scholar
• ConsultationWHOEAppropriate body-mass index for asian populations and its implications for policy and intervention strategiesLancet200436315716314726171
   PubMed Web of Science ®Google Scholar
• FabbriLMLuppiFBegheBRabeKFComplex chronic comorbidities of COPDEur Respir J20083120421218166598
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest20051282099210716236861
   PubMed Web of Science ®Google Scholar
• WagnerPDPossible mechanisms underlying the development of cachexia in COPDEur Respir J20083149250118310396
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318772873523392440
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J20083296296918579551
   PubMed Web of Science ®Google Scholar
• CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol200616637016039877
   PubMed Web of Science ®Google Scholar
• MillerJEdwardsLDAgustiAEvaluation of CLtIPSEI. Comorbidity, systemic inflammation and outcomes in the eclipse cohortRespir Med20131071376138423791463
   PubMed Web of Science ®Google Scholar
• TanWCNgTPCOPD in Asia: where east meets westChest200813351752718252918
   PubMed Web of Science ®Google Scholar
• JooHParkJLeeSDOhYMComorbidities of chronic obstructive pulmonary disease in koreans: a population-based studyJ Korean Med Sci20122790190622876057
   PubMed Web of Science ®Google Scholar
• SteutenLMCreutzbergECVrijhoefHJWoutersEFCOPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary carePrim Care Respir J200615849116701766
   PubMedGoogle Scholar
• KimSBKangYAJungJYBody mass index and fat free mass index in obstructive lung disease in KoreaInt J Tuberc Lung Dis20141810210824365561
   PubMed Web of Science ®Google Scholar
• BaarendsEMScholsAMPannemansDLWesterterpKRWoutersEFTotal free living energy expenditure in patients with severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19971555495549032193
   PubMed Web of Science ®Google Scholar
• DebigareRMarquisKCoteCHCatabolic/anabolic balance and muscle wasting in patients with COPDChest2003124838912853506
   PubMed Web of Science ®Google Scholar
• EidAAIonescuAANixonLSInflammatory response and body composition in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011641414141811704588
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
   PubMed Web of Science ®Google Scholar
• LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991601856186110588597
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201218615516122561964
   PubMed Web of Science ®Google Scholar
• MapelDWDedrickDDavisKTrends and cardiovascular co-morbidities of COPD patients in the veterans administration medical system, 1991–1999COPD20052354117136959
   PubMedGoogle Scholar
• AgustiACalverleyPMCelliBEvaluation of CLtIPSEiCharacterisation of COPD heterogeneity in the eclipse cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• BatyFPutoraPMIsenringBBlumTBrutscheMComorbidities and burden of COPD: A population based case-control studyPLoS One20138e6328523691009
   PubMed Web of Science ®Google Scholar
• SmithMCWrobelJPEpidemiology and clinical impact of major comorbidities in patients with COPDInt J Chron Obstruct Pulmon Dis2014987188825210449
   PubMed Web of Science ®Google Scholar
• HolguinFFolchEReddSCManninoDMComorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001Chest20051282005201116236848
   PubMed Web of Science ®Google Scholar
• BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med200912234835519332230
   PubMed Web of Science ®Google Scholar
• FabbriLMRabeKFFrom COPD to chronic systemic inflammatory syndrome?Lancet200737079779917765529
   PubMed Web of Science ®Google Scholar
• ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc2008554955518453370
   PubMedGoogle Scholar
• SpiesCMStrehlCvan der GoesMCBijlsmaJWButtgereitFGlucocorticoidsBest Pract Res Clin Rheumatol20112589190022265268
   PubMed Web of Science ®Google Scholar
• LaviSPrasadAYangEHSmoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery diseaseCirculation20071152621262717485580
   PubMed Web of Science ®Google Scholar
• BasiliSFerroniPVieriMLipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary diseaseAtherosclerosis199914724925210559510
   PubMed Web of Science ®Google Scholar
• HumayunAShahASAlamSHusseinHRelationship of body mass index and dyslipidemia in different age groups of male and female population of PeshawarJ Ayub Med Coll Abbottabad20092114114420524492
   PubMedGoogle Scholar
• MalnickSDKnoblerHThe medical complications of obesityQJM20069956557916916862
   PubMed Web of Science ®Google Scholar
• IzquierdoJLMartinezAGuzmanEde LucasPRodriguezJMLack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factorsInt J Chron Obstruct Pulmon Dis2010538739421103405
   PubMedGoogle Scholar
• SilverbergDSMorRWeuMTSchwartzDSchwartzIFCherninGAnemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous ironBMC Pulm Med2014142424564844
   PubMed Web of Science ®Google Scholar
• SimilowskiTAgustiAMacNeeWSchonhoferBThe potential impact of anaemia of chronic disease in COPDEur Respir J20062739039616452598
   PubMed Web of Science ®Google Scholar
• JohnMLangeAHoernigSWittCAnkerSDPrevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseasesInt J Cardiol200611136537016242192
   PubMed Web of Science ®Google Scholar
• BoutouAKHopkinsonNSPolkeyMIAnaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiologyClin Sci201512828329525394288
   PubMed Web of Science ®Google Scholar
• BoltonCECannings-JohnREdwardsPHWhat community measurements can be used to predict bone disease in patients with COPD?Respir Med200810265165718308533
   PubMed Web of Science ®Google Scholar
• BoltonCEIonescuAAShielsKMAssociated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20041701286129315374843
   PubMed Web of Science ®Google Scholar
• KjensliAMowinckelPRygMSFalchJALow bone mineral density is related to severity of chronic obstructive pulmonary diseaseBone20074049349717049326
   PubMed Web of Science ®Google Scholar
• VriezeAde GreefMHWijkstraPJWempeJBLow bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free massOsteoporos Int2007181197120217347789
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax20045957458015223864
   PubMed Web of Science ®Google Scholar
• Graat-VerboomLWoutersEFSmeenkFWvan den BorneBELundeRSpruitMACurrent status of research on osteoporosis in COPD: a systematic reviewEur Respir J20093420921819567604
   PubMed Web of Science ®Google Scholar
• MapelDWHurleyJSFrostFJPetersenHVPicchiMACoultasDBHealth care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organizationArch Intern Med20001602653265810999980
   PubMed Web of Science ®Google Scholar
• SchnellKWeissCOLeeTThe prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008BMC Pulm Med2012122622695054
   PubMed Web of Science ®Google Scholar
• Echave-SustaetaJMCasanovaLCCosioBGSoler-CataluñaJJGarcia-LujanRComorbidity in chronic obstructive pulmonary disease. Related to disease severity?Int J Chron Obstruct Pulmon Dis201491307131425429213
   PubMed Web of Science ®Google Scholar